Compass Therapeutics
CMPX
CMPX
200 hedge funds and large institutions have $919M invested in Compass Therapeutics in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.91% more ownership
Funds ownership: 92.29% → 96.2% (+3.9%)
4% more capital invested
Capital invested by funds: $881M → $919M (+$37.6M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
200
Holding in Top 10
5
Calls
$19.2M
Puts
$1.11M
Top Buyers
| 1 | +$23.4M | |
| 2 | +$12.8M | |
| 3 | +$12.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$11.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$13.1M | |
| 3 | -$7.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$7.56M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$6.79M |
